346 related articles for article (PubMed ID: 11527700)
1. T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.
Demeure CE; Wolfers J; Martin-Garcia N; Gaulard P; Triebel F
Eur J Cancer; 2001 Sep; 37(13):1709-18. PubMed ID: 11527700
[TBL] [Abstract][Full Text] [Related]
2. Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223).
Andreae S; Piras F; Burdin N; Triebel F
J Immunol; 2002 Apr; 168(8):3874-80. PubMed ID: 11937541
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes.
Huard B; Tournier M; Hercend T; Triebel F; Faure F
Eur J Immunol; 1994 Dec; 24(12):3216-21. PubMed ID: 7805750
[TBL] [Abstract][Full Text] [Related]
4. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
5. The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.
Hannier S; Triebel F
Int Immunol; 1999 Nov; 11(11):1745-52. PubMed ID: 10545478
[TBL] [Abstract][Full Text] [Related]
6. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
[TBL] [Abstract][Full Text] [Related]
7. Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway.
Di Carlo E; Cappello P; Sorrentino C; D'Antuono T; Pellicciotta A; Giovarelli M; Forni G; Musiani P; Triebel F
J Pathol; 2005 Jan; 205(1):82-91. PubMed ID: 15586367
[TBL] [Abstract][Full Text] [Related]
8. MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells.
Buisson S; Triebel F
Vaccine; 2003 Feb; 21(9-10):862-8. PubMed ID: 12547595
[TBL] [Abstract][Full Text] [Related]
9. The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells.
Maçon-Lemaître L; Triebel F
Immunology; 2005 Jun; 115(2):170-8. PubMed ID: 15885122
[TBL] [Abstract][Full Text] [Related]
10. CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins.
Huard B; Prigent P; Tournier M; Bruniquel D; Triebel F
Eur J Immunol; 1995 Sep; 25(9):2718-21. PubMed ID: 7589152
[TBL] [Abstract][Full Text] [Related]
11. T cell major histocompatibility complex class II molecules down-regulate CD4+ T cell clone responses following LAG-3 binding.
Huard B; Prigent P; Pagès F; Bruniquel D; Triebel F
Eur J Immunol; 1996 May; 26(5):1180-6. PubMed ID: 8647185
[TBL] [Abstract][Full Text] [Related]
12. Analysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity.
Angevin E; Kremer F; Gaudin C; Hercend T; Triebel F
Int J Cancer; 1997 Jul; 72(3):431-40. PubMed ID: 9247286
[TBL] [Abstract][Full Text] [Related]
13. A soluble lymphocyte activation gene-3 molecule used as a vaccine adjuvant elicits greater humoral and cellular immune responses to both particulate and soluble antigens.
El Mir S; Triebel F
J Immunol; 2000 Jun; 164(11):5583-9. PubMed ID: 10820232
[TBL] [Abstract][Full Text] [Related]
14. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte activation gene-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-12 production by monocytes and dendritic cells.
Avice MN; Sarfati M; Triebel F; Delespesse G; Demeure CE
J Immunol; 1999 Mar; 162(5):2748-53. PubMed ID: 10072520
[TBL] [Abstract][Full Text] [Related]
16. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
17. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
18. Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II.
Bruniquel D; Borie N; Hannier S; Triebel F
Immunogenetics; 1998 Jul; 48(2):116-24. PubMed ID: 9634475
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte activation gene-3 induces tumor regression and antitumor immune responses.
Prigent P; El Mir S; Dréano M; Triebel F
Eur J Immunol; 1999 Dec; 29(12):3867-76. PubMed ID: 10601994
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor.
Baxevanis CN; Voutsas IF; Tsitsilonis OE; Gritzapis AD; Sotiriadou R; Papamichail M
J Immunol; 2000 Apr; 164(7):3902-12. PubMed ID: 10725753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
